Israel Englander Ginkgo Bioworks Holdings, Inc. Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $2.35 Million - $9.74 Million	-8,395,197 Reduced 79.39%	2,179,904 $719,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $1.39 Million - $2.19 Million	1,308,697 Added 14.12%	10,575,101 $12.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $2.5 Million - $3.55 Million	1,985,804 Added 27.28%	9,266,404 $15.7 Million
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $8.3 Million - $14.2 Million	7,280,600 New	7,280,600 $13.5 Million
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $2.15 Million - $11 Million	-2,949,281 Reduced 96.41%	109,710 $342,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.